App for cancer depression fails to launch: trial ends after just one participant

NCT ID NCT06472726

First seen Jun 27, 2026 · Last updated Jul 31, 2026 · Updated 2 times

Summary

This study aimed to see if a smartphone app called IONA Mind could help treat depression in people who have had head and neck cancer. Participants would use the app for 6 weeks and fill out surveys. However, the trial was terminated early after enrolling only 1 person, so no meaningful results were obtained.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
IONA Mind app (a smartphone app for mental health support)
What this could lead to
If it worked, this could point toward a convenient, app-based way to ease depression in head and neck cancer survivors.
What could go wrong
The trial was terminated after enrolling only 1 person, so we have almost no data. It is too early to know if the app helps or is even usable in this group.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DEPRESSION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Depression depressive disorder head and neck cancer Head and Neck Neoplasms

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • University of Wisconsin Carbone Cancer Center

    Madison, Wisconsin, 53705, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.